They also have different sample sizes not only between the datasets but also inside them—for example, more cell lines and patients have LoF mutations in common cancer genes such as TP53 or RB1, which can be part of the reason for their high position in the list ranked by combined p-values. This evidence concerns the gene TP53 and cancer.